Global Octreotide Supply, Demand and Key Producers, 2026-2032

The global Octreotide market size is expected to reach $ 2.35 million by 2032, rising at a market growth of -2.7% CAGR during the forecast period (2026-2032).

Octreotide is an octapeptide that mimics natural somatostatin pharmacologically，it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. Usually in the form of a salt of acetic acid.

Global Octreotide key players include Novartis, SUN, Tiantaishan pharmaceutical, Sinopharm A-Think, Sihuan Pharmaceutical, etc. Global top five manufacturers hold a share over 90%.

Europe is the largest market, with a share over 65%, followed by India and China, both have a share over 30%.

This report studies the global Octreotide production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Octreotide and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Octreotide that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Octreotide total production and demand, 2021-2032, (Gram)

Global Octreotide total production value, 2021-2032, (USD Million)

Global Octreotide production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (Gram), (based on production site)

Global Octreotide consumption by region & country, CAGR, 2021-2032 & (Gram)

U.S. VS China: Octreotide domestic production, consumption, key domestic manufacturers and share

Global Octreotide production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (Gram)

Global Octreotide production by Type, production, value, CAGR, 2021-2032, (USD Million) & (Gram)

Global Octreotide production by Application, production, value, CAGR, 2021-2032, (USD Million) & (Gram)

This report profiles key players in the global Octreotide market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis, Sun Pharmaceutical, Chengdu Tiantaishan pharmaceutical, Sinopharm A-Think Pharmaceuticals, Sihuan Pharmaceutical Holdings Group, Shanghai Soho-Yiming Pharmaceuticals, Yibin Pharmaceutical, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Octreotide market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Gram) and average price (USD/Gram) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.

Global Octreotide Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Octreotide Market, Segmentation by Type:
Octreotide Injection
Octreotide Powder
Octreotide Microspheres

Global Octreotide Market, Segmentation by Application:
Treating Severe Diarrhea
Treating Acromegaly
Others

Companies Profiled:
Novartis
Sun Pharmaceutical
Chengdu Tiantaishan pharmaceutical
Sinopharm A-Think Pharmaceuticals
Sihuan Pharmaceutical Holdings Group
Shanghai Soho-Yiming Pharmaceuticals
Yibin Pharmaceutical

Key Questions Answered:

1. How big is the global Octreotide market?

2. What is the demand of the global Octreotide market?

3. What is the year over year growth of the global Octreotide market?

4. What is the production and production value of the global Octreotide market?

5. Who are the key producers in the global Octreotide market?

6. What are the growth factors driving the market demand? Show more